These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6933906)

  • 21. Tris(2,3-dibromopropyl) phosphate.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1979 Oct; 20():575-88. PubMed ID: 397179
    [No Abstract]   [Full Text] [Related]  

  • 22. Bis (2,3-dibromopropyl) phosphate nephrotoxicity: effect of sex and CoCl2 pretreatment.
    Elliott WC; Koski J; Houghton DC; Hunter-Baines J; Bennett WM; Lynn RK
    Life Sci; 1983 Mar; 32(10):1107-17. PubMed ID: 6827891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation mechanism of tris(2,3-dibromopropyl)phosphate to the potent mutagen, 2-bromoacrolein.
    Nelson SD; Omichinski JG; Iyer L; Gordon WP; Soderlund EJ; Dybing E
    Biochem Biophys Res Commun; 1984 May; 121(1):213-9. PubMed ID: 6375666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo and in vitro biological effects of the flame retardants tris(2,3-dibromopropyl) phosphate and tris(2-chlorethyl)orthophosphate.
    Sala M; Gu ZG; Moens G; Chouroulinkov I
    Eur J Cancer Clin Oncol; 1982 Dec; 18(12):1337-44. PubMed ID: 6891932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenesis of toxic and neoplastic renal lesions induced by the flame retardant tris (2,3-dibromopropyl)phosphate in F344 rats, and development of colonic adenomas after prolonged oral administration.
    Reznik G; Reznik-Schüller HM; Rice JM; Hague BF
    Lab Invest; 1981 Jan; 44(1):74-83. PubMed ID: 7453132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal and testicular damage following dermal application of the flame retardant tris (2,3-dibromopropyl) phosphate.
    Osterberg RE; Bierbower GW; Hehir RM
    J Toxicol Environ Health; 1977 Dec; 3(5-6):979-87. PubMed ID: 599593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genotoxicity of the flame retardant tris(2,3-dibromopropyl)phosphate in the rat and Drosophila: effects of deuterium substitution.
    van Beerendonk GJ; Nivard MJ; Vogel EW; Nelson SD; Meerman JH
    Carcinogenesis; 1994 Jun; 15(6):1197-202. PubMed ID: 8020156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutagenicity of derivatives of the flame retardant tris(2,3-dibromopropyl) phosphate: halogenated propanols.
    Carr HS; Rosenkranz HS
    Mutat Res; 1978 Jul; 57(3):381-4. PubMed ID: 353552
    [No Abstract]   [Full Text] [Related]  

  • 29. Neurotoxicological and thyroid evaluations of rats developmentally exposed to tris(1,3-dichloro-2-propyl)phosphate (TDCIPP) and tris(2-chloro-2-ethyl)phosphate (TCEP).
    Moser VC; Phillips PM; Hedge JM; McDaniel KL
    Neurotoxicol Teratol; 2015; 52(Pt B):236-47. PubMed ID: 26300399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diester metabolites of the flame retardant chemicals, tris(1,3-dichloro-2-propyl)phosphate and tris(2,3-dibromopropyl) phosphate in the rat: identification and quantification.
    Lynn RK; Wong K; Dickinson RG; Gerber N; Kennish JM
    Res Commun Chem Pathol Pharmacol; 1980 May; 28(2):351-60. PubMed ID: 7394328
    [No Abstract]   [Full Text] [Related]  

  • 31. Children absorb tris-BP flame retardant from sleepwear: urine contains the mutagenic metabolite, 2,3-dibromopropanol.
    Blum A; Gold MD; Ames BN; Jones FR; Hett EA; Dougherty RC; Horning EC; Dzidic I; Carroll DI; Stillwell RN; Thenot JP
    Science; 1978 Sep; 201(4360):1020-3. PubMed ID: 684422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolism in vitro of tris(2,3-dibromopropyl)-phosphate: oxidative debromination and bis(2,3-dibromopropyl)phosphate formation as correlates of mutagenicity and covalent protein binding.
    Søderlund EJ; Gordon WP; Nelson SD; Omichinski JG; Dybing E
    Biochem Pharmacol; 1984 Dec; 33(24):4017-23. PubMed ID: 6508849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of mammalian mutagenicity of the potent bacterial mutagen tris(2,3-dibromopropyl) phosphate and its metabolite 2-bromoacrolein.
    van Beerendonk GJ; Klein JC; Tijdens RB; Lichtenauer-Kaligis EG; Tasseron-de Jong JG; Meerman JH
    Mutat Res; 1998 Jul; 415(3):201-11. PubMed ID: 9714806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo binding of the flame retardants tris(2,3-dibromopropyl) phosphate and tris(1,3-dichloro-2-propyl) phosphate to macromolecules of mouse liver, kidney and muscle.
    Morales NM; Matthews HB
    Bull Environ Contam Toxicol; 1980 Jul; 25(1):34-8. PubMed ID: 6161654
    [No Abstract]   [Full Text] [Related]  

  • 35. Organ-specific DNA damage of tris(2,3-dibromopropyl)-phosphate and its diester metabolite in the rat.
    Søderlund EJ; Brunborg G; Dybing E; Trygg B; Nelson SD; Holme JA
    Chem Biol Interact; 1992 Apr; 82(2):195-207. PubMed ID: 1568270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutagenic activation of tris(2,3-dibromopropyl)phosphate: the role of microsomal oxidative metabolism.
    Søderlund EJ; Nelson SD; Dybing E
    Acta Pharmacol Toxicol (Copenh); 1979 Aug; 45(2):112-21. PubMed ID: 40390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing in-vitro estrogenic effects of currently-used flame retardants.
    Krivoshiev BV; Dardenne F; Covaci A; Blust R; Husson SJ
    Toxicol In Vitro; 2016 Jun; 33():153-62. PubMed ID: 26979758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolism and genotoxicity of the halogenated alkyl compound tris(2,3-dibromopropyl)phosphate.
    van Beerendonk GJ; Nelson SD; Meerman JH
    Hum Exp Toxicol; 1994 Dec; 13(12):861-5. PubMed ID: 7718306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The flame retardant tris (2, 3-dibromopropyl) phosphate: alteration of human cellular DNA.
    Gutter B; Rosenkranz HS
    Mutat Res; 1977 Sep; 56(1):89-90. PubMed ID: 593298
    [No Abstract]   [Full Text] [Related]  

  • 40. Mutagenicity of Tris(2,3-dibromopropyl) phosphate in mammalian gonad and bone marrow tissue.
    Salamone MF; Katz M
    J Natl Cancer Inst; 1981 Apr; 66(4):691-5. PubMed ID: 6939915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.